Private company

ALBIREO PHARMA, INC.

Last updated Oct 16, 2026.

Overview

  • IndustryPharmaceutical Preparations
  • HeadquartersDE
  • Incorporated inDE2
  • Business address10 Post Office Square, Suite 502 South, Boston, Ma 021092
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2021

96.7%Gross margin3
-304.3%Operating margin3
-83.9%Net margin3
388.4%Revenue growth, 20213
-19.4%Return on equity3
-$108.0MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2021

  • Cost of revenue1¢$1.4M
  • Research and development54¢$82.5M
  • Selling, general and admin45¢$69.6M

Out of $40.6M in revenue.3 The company lost money this year.

Financial statements

Revenue456783$40.6M in 2021+696% since 2015
0$20.0M$40.0M$60.0M2015: $5.1M$5.1M20152016: $11.4M$11.4M2016+123%2017: $1.0K$1.0K2017−100%2018: $12.7M$12.7M2018+1273900%2019: $9.6M$9.6M2019−24%2020: $8.3M$8.3M2020−14%2021: $40.6M$40.6M2021+388%
Gross profit3$39.2M in 2021+372% since 2020
0$10.0M$20.0M$30.0M$40.0M2020: $8.3M$8.3M20202021: $39.2M$39.2M2021+372%
Operating income456783-$123.5M in 2021+2513% since 2015
-$150.0M-$100.0M-$50.0M02015: -$4.7M-$4.7M20152016: -$12.3M-$12.3M2016+160%2017: -$24.6M-$24.6M2017+100%2018: -$37.9M-$37.9M2018+54%2019: -$61.1M-$61.1M2019+61%2020: -$96.3M-$96.3M2020+58%2021: -$123.5M-$123.5M2021+28%
Net income456783-$34.0M in 2021+403% since 2015
-$150.0M-$100.0M-$50.0M02015: -$6.8M-$6.8M20152016: -$16.4M-$16.4M2016+142%2017: -$24.4M-$24.4M2017+49%2018: -$46.1M-$46.1M2018+89%2019: -$62.7M-$62.7M2019+36%2020: -$107.6M-$107.6M2020+72%2021: -$34.0M-$34.0M2021−68%
Fiscal year2015201620172018201920202021
Revenue$5.1M4$11.4M5$1.0K6$12.7M7$9.6M8$8.3M3$40.6M3
Cost of revenue$1.4M3
Gross profit$8.3M3$39.2M3
Research and development$5.6M4$8.1M5$13.0M6$31.7M7$45.6M8$76.8M3$82.5M3
Selling, general and admin$42.4M3$69.6M3
Operating income-$4.7M4-$12.3M5-$24.6M6-$37.9M7-$61.1M8-$96.3M3-$123.5M3
Income tax$04$62.0K5$212.0K6$20.0K7
Net income-$6.8M4-$16.4M5-$24.4M6-$46.1M7-$62.7M8-$107.6M3-$34.0M3
Earnings per share-$6.733-$1.773
Earnings per share (diluted)-$6.733-$1.773

Compare ALBIREO PHARMA, INC. with another company

Former names

  • Biodel IncMar 28, 2005 to Nov 2, 20162

Recent filings

  1. Mar 3, 20234 FORM 4 SUBMISSION
  2. Mar 2, 20238-K
  3. Mar 2, 20234 FORM 4 SUBMISSION
  4. Mar 2, 20234 FORM 4 SUBMISSION
  5. Mar 2, 20234 FORM 4 SUBMISSION
  6. Mar 2, 20234 FORM 4 SUBMISSION
  7. Mar 2, 20234 FORM 4 SUBMISSION
  8. Mar 2, 20234 FORM 4 SUBMISSION
  9. Mar 2, 20234 FORM 4 SUBMISSION
  10. Mar 2, 20234 FORM 4 SUBMISSION
  11. Mar 2, 20234 FORM 4 SUBMISSION
  12. Mar 2, 20234 FORM 4 SUBMISSION
  13. Mar 2, 20234 FORM 4 SUBMISSION
  14. Mar 2, 20234 FORM 4 SUBMISSION
  15. Mar 2, 20234 FORM 4 SUBMISSION

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9